AVADEL PHARMACEUTICALS PLC - SPONSORED ADR - Call Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q2 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Calls Notional Value	Price (Median)
2024 Q2	$0
2024 Q1	$7,492,404	$16.89
2023 Q4	$3,707,912	$14.12
2023 Q3	$3,073,520	$10.30
2023 Q2	$9,887,692	$16.48
2023 Q1	$3,678,140	$9.16
2022 Q4	$3,345,616	$7.16
2022 Q3	$1,567,000	$5.01
2022 Q2	$292,000	$2.44
2022 Q1	$544,000	$3.56
2021 Q4	$1,011,000	$8.08
2021 Q3	$2,341,000	$9.80
2021 Q2	$3,685,000	$6.73
2021 Q1	$5,009,000	$9.04
2020 Q4	$269,000	$6.67
2020 Q3	$83,000	$5.03
2020 Q2	$3,895,000	$8.08
2020 Q1	$6,143,000	$7.94
2019 Q4	$2,318,000	$7.55
2019 Q3	$347,000	$4.16
2019 Q2	$23,000	$2.88
2018 Q3	$0
2018 Q2	$314,000	$6.12
2018 Q1	$440,000	$7.28
2017 Q4	$8,000	$8.00